Allows an organization or entity to establish and administer a cancer clinical trial participation program for the purpose of providing payments to a participant for certain costs incurred by the participant while participating in a cancer clinical trial. Sets forth program requirements and participant eligibility.

Statutes affected:
Introduced House Bill (H): 16-18-2-294.5
House Bill (H): 16-18-2-294.5
House Bill (S): 16-18-2-294.5
Enrolled House Bill (H): 16-18-2-294.5